A large, prospective study implicates high levels of interleukin 6 with severity of diabetic retinopathy and shows it may be ...

Eli Lilly and Company (NYSE:LLY) is one of Goldman Sachs’ top healthcare stock picks. On July 9, the company confirmed the ...

CNW/ - Springbok Analytics, a leader in AI-driven muscle analytics, today announced the publication in Scientific Reports of a new disease progression model for facioscapulohumeral muscular dystrophy ...

Patients were treated with MIPLYFFA in a 48-month open-label extension (OLE) study following the Phase 2/3, randomized, double-blind, placebo-controlled pivotal trial. The OLE data demonstrate that ...

Tooth inflammation during pregnancy should not be taken lightly as it can have a significant impact on the fetus. Gingivitis ...

The human body requires salt to maintain proper fluid levels, and regulate the nerve system. However, the consumption of ...

A recent bee attack in France left 24 injured and three in critical condition. While bee attacks aren't common, there are ...

Lilly's Kisunla gets FDA approval for a new dosing schedule that significantly lowers ARIA-E risk while maintaining amyloid ...

Ingelheim, Germany Tuesday, July 8, 2025, 14:00 Hrs [IST] ...

A class of drugs, MDM2 inhibitors, being studied as cancer therapeutics may accidentally damage the protective barriers in the brain and eyes, finds new research in mice.